Valtari
63 Hatton Garden Suite 23, London, EC1N 8LE, United Kingdom
Overview
Valtari Ltd. is a firm offering mergers and acquisitions research services. Valtari specializes in providing advisory via its "Full-Time M&A Analyst" service, which affords its clients unfettered support from a dedicated in-house M&A analyst to develop the following: sell-side deal research; buy-side deal origination; pitch book preparation; writing and designing confidential information memoranda (CIMs); and modeling. Valtari also offers additional back office support services, such as developing email campaigns for marketing deals and acquisitive growth opportunities — while its team manages the validation of key contact information, email template design, execution, and analytics. Valtari Ltd. was founded in 2016 and is headquartered in London with an additional office in New York.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Analytics
- Consulting
- Finance
- Management Consulting
- Market Research
- Marketing
- Presentations
Investment portfolio
- iMICROQ
Participated · Equity · Aug 2017
iMiCROQ is a 2010 spin‑off from Universitat Rovira i Virgili based in Tarragona that develops the QFast® analytical platform for integrated detection of pathogens, DNA, viruses and toxins. The company offers instrumentation packs and kits currently for detection of Salmonella spp. in veterinary, environmental and food samples, with Gen‑QFast® Listeria monocytogenes and QFast® Sakazakii kits undergoing certification. QFast® has been implemented in ISO 17025 accredited laboratories, internal control labs, poultry integrations, feed and raw‑material producers, animal health companies and SMEs in the food sector. The platform supports ELISA/ELONA‑type assays with technical advantages that reduce interference, handling and total time while improving sensitivity, enabling in‑situ diagnostic applications in veterinary and clinical areas. iMiCROQ has 14 employees and positions its commercial, marketing and product development activities to consolidate QFast® as a reference brand in rapid microbiological diagnostics. The company plans to expand its portfolio for agro‑food safety and advance international commercialization in the coming years. iMICROQ develops low-cost, integrated screen-printed microsystems for rapid detection and identification of pathogenic agents, including its QFast Salmonella kit. The company plans to use the funds to accelerate international validation activities and to run industrial and production tests to begin international commercialization of the Salmonella kit. It raised €1.1M in the reported funding round. iMICROQ was founded in 2010 and is based in Tarragona, Spain. The technology was developed at the University Rovira i Virgili’s Advanced Innovation Technology Centre (ATIC). The company was founded by Ioanis Katakis, Pablo Lozano, Diego Bejarano, Maria Viviana Duarte and Carlos Arias.
Team
No current team members are available.